The prevalence and risk factors associated with pulmonary arterial hypertension among HIV-infected individuals in a tertiary hospital in Durban

Abstract

Human Immunodeficiency Virus (HIV) infection continues to be a major global public health burden and a risk factor for developing pulmonary arterial hypertension (PAH). Africa carries the largest burden of HIV globally. However, data summarizing the epidemiology of PAH remains unclear. The lungs are often affected by disorders associated with HIV-infection. HIV-infected individuals are at an increased risk of developing PAH and dying from the condition compared to the general population. This study aims to determine the prevalence of PAH, and the risk factors associated with it in individuals living with HIV in a healthcare facility in Durban between 2022 and 2023